The Food and Drug Administration has approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for ...

A team discovers a new family of enzymes capable of inducing targeted cuts in single-stranded DNA A few years ago, the advent of technology known as CRISPR was a major breakthrough in the scientific ...

A new family of enzymes enables precise cuts in single-stranded DNA, offering powerful new tools for genetic engineering and ...

Learn more about whether Amarin Corporation plc or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor ...

Learn more about whether CRISPR Therapeutics AG or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ ...

Recent IVG breakthroughs bring gene-edited human embryos closer, with CRISPR-Cas9 making heritable gene editing a reality ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...

Scientists have developed a novel gene editing tool that could have vast implications for research and therapeutics. This technology is called STITCHR ... | Genetics And Genomics ...

Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.

A consortium of EU-based scientists and bioethicists raise concerns about the implications and threats of artificial ...